Insider trades
Jerome B. Zeldis, Director of PTC Therapeutics PTCT, has filed 3 purchases and 6 sales on the open market. The latest trade was on 01/02.
Jerome B. Zeldis
Director
- Company
- PTC Therapeutics PTCT
- First filing
- 23/01/09
- Trades
- 31 trades
- Buys / sales
- 3 / 6
- 12-month net buying
- No record
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
PTCT | Open-market sale10b5-1 plan | 24/12/02 | 24/12/04 | 24,000 sh5 trades | $51.50avg. | $1,235,897.49 | −62.3% |
NexgelNXGL | Open-market buy | 24/11/20 | 24/11/22 | 3,636 sh | $2.75 | $9,999 | +3.5% |
NexgelNXGL | Open-market buy | 24/08/23 | 24/08/27 | 10,000 sh | $2.50 | $25,000 | +10.7% |
PTC TherapeuticsPTCT | Open-market sale10b5-1 plan | 24/05/22 | 24/05/24 | 20,000 sh | $38.24 | $764,800 | −58.0% |
NexgelNXGL | Open-market buy | 23/05/26 | 23/05/30 | 5,000 sh | $2.34 | $11,700 | +5.7% |
